体外心肺复苏患者发生下肢缺血的风险:SAVE-J II 研究二次分析
该研究为SAVE-J II全国多中心回顾性研究的二次分析,纳入2013至2018年36家机构中因院外心脏骤停接受体外心肺复苏的成年患者969例。下肢缺血定义为需要治疗性远端灌注导管、筋膜切开或截肢,发生率为7.4%(72例)。多变量分析显示,预防性放置远端灌注导管与下肢缺血风险降低相关(OR 0.20,95%CI 0.07-0.55),插管相关出血(OR 1.83,95%CI 1.06-3.14)和导管异位(OR 3.81,95%CI 1.68-8.64)与风险升高相关。作者认为,对于存在插管相关并发症的患者应预期下肢缺血,可考虑预防性放置远端灌注导管以降低风险。
要点
- 在969例体外心肺复苏患者中,下肢缺血发生率为7.4%(72例),定义为需要治疗性远端灌注导管、筋膜切开或截肢。
- 预防性远端灌注导管的使用率在下肢缺血患者中为5.6%(4例),在无下肢缺血患者中为24.4%(219例),p<0.001。
- 多变量分析显示,预防性放置远端灌注导管与下肢缺血风险降低独立相关(OR 0.20,95%CI 0.07-0.55)。
- 插管相关出血(OR 1.83,95%CI 1.06-3.14)和导管异位(OR 3.81,95%CI 1.68-8.64)与下肢缺血风险升高独立相关。
- 作者结论指出,对于存在插管相关并发症的患者应预期下肢缺血,可考虑预防性放置远端灌注导管以降低风险。
适用人群与场景
- 因院外心脏骤停接受体外心肺复苏的成年患者,来自日本36家机构,2013至2018年。
诊断标准与关键阈值
- 下肢缺血定义为需要治疗性远端灌注导管、筋膜切开或截肢。
红旗征与不能漏的情况
- 插管相关出血患者下肢缺血发生率为30.6%(22例),无下肢缺血患者为18.1%(162例),p=0.009。
- 导管异位患者下肢缺血发生率为12.5%(9例),无下肢缺血患者为3.2%(29例),p<0.001。
研究设计与关键结果
- 研究设计为全国多中心回顾性研究的二次分析,纳入969例接受体外心肺复苏的成年院外心脏骤停患者,来自36家机构(2013至2018年)。
- 下肢缺血发生率为7.4%(72/969)。
- 下肢缺血组与无下肢缺血组在基线特征、插管位置、穿刺方法或静脉-动脉体外膜氧合导管尺寸方面无显著差异。
- 预防性远端灌注导管使用率:下肢缺血组5.6%(4例) vs 无下肢缺血组24.4%(219例),p<0.001。
- 多变量分析显示,预防性远端灌注导管放置与下肢缺血风险降低相关(OR 0.20,95%CI 0.07-0.55;p=0.002)。
- 插管相关出血与下肢缺血风险升高相关(OR 1.83,95%CI 1.06-3.14;p=0.030)。
- 导管异位与下肢缺血风险升高相关(OR 3.81,95%CI 1.68-8.64;p=0.001)。
证据类型、等级与局限
- 证据类型:全国多中心回顾性研究的二次分析(post hoc分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于存在插管相关并发症的患者应预期下肢缺血,可考虑预防性放置远端灌注导管以降低下肢缺血风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: While potential risks for limb ischemia have been explored in studies of venoarterial extracorporeal membrane oxygenation (ECMO), they remain inadequately defined for patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR). We identified risk factors for the development of lower limb ischemia during ECPR using a large nationwide ECPR cohort.
DESIGN: A post hoc analysis was conducted using a nationwide, multicenter, retrospective study (Study of Advanced Cardiac Life Support for Ventricular Fibrillation with Extracorporeal Circulation in Japan II [SAVE-J II]).
SETTING: Thirty-six institutions from 2013 to 2018.
PATIENTS: Adult patients who underwent ECPR for out-of-hospital cardiac arrest.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Lower limb ischemia was defined as the requirement for a therapeutic distal perfusion catheter (DPC), fasciotomy, or amputation. Risk factors for lower limb ischemia were assessed using multivariate logistic regression models that included patient characteristics, ECPR-related information, and resuscitation content as potential confounders. Of the 969 patients, 72 (7.4%) developed lower limb ischemia. No significant differences were observed regarding background characteristics, cannulation location, puncture method, or venoarterial ECMO catheter size between patients with and without limb ischemia. However, a prophylactic DPC was less frequently employed in patients with lower limb ischemia than in those without (4 [5.6%] vs. 219 [24.4%]; p < 0.001). Higher incidences of cannulation-related bleeding and cannula malposition were observed in patients with limb ischemia than in those in patients without limb ischemia (22 [30.6%] vs. 162 [18.1%]; p = 0.009 and 9 [12.5%] vs. 29 [3.2%]; p < 0.001, respectively). Multivariable analyses revealed that prophylactic DPC placement was associated with a lower risk of limb ischemia (0.20 [0.07-0.55]; p = 0.002), whereas cannulation-related bleeding and cannula malposition were linked to an increased risk of lower limb ischemia (1.83 [1.06-3.14]; p = 0.030 and 3.81 [1.68-8.64]; p = 0.001, respectively).
CONCLUSIONS: Lower limb ischemia during ECPR would be anticipated in patients with cannulation-related complications, and prophylactic DPC placement may be considered to mitigate the risk of lower limb ischemia.
参考来源
- Matsumura K, Yamamoto R, Kaito D, et al. Risk of Developing Lower Limb Ischemia in Patients With Extracorporeal Cardiopulmonary Resuscitation: A Secondary Analysis of the Study of Advanced Cardiac Life Support for Ventricular Fibrillation With Extracorporeal Circulation in Japan II (SAVE-J II) Study. Crit Care Med. 2025. PMID: 41467753. doi:10.1097/CCM.0000000000007010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。